New R21 Awarded to DC CFAR Investigator Dr. Natalia Soriano-Sarabia on "Allogeneic cytotoxic gammadelta T cells for HIV cure immunotherapy"

Please join us in congratulating DC CFAR investigator Dr. Natalia Soriano-Sarabia (GW) who was recently awarded an R21 from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) entitled "Allogeneic cytotoxic gammadelta T cells for HIV cure immunotherapy". This study aims to further investigate the clinical use of immunotherapies based on gammadelta T cells for HIV cure treatments.